1. Can the Problem of Female Genital Mutilation be Solved?

    20/08/2024 -

    FGM is a health, social and economic problem that should be addressed through on-the-ground interventions and technological solutions

  2. Women and Drugs: Gender Inequality in Access to Health Services

    30/07/2024 -

    For a woman, accessing addiction treatment services can be a path strewn with obstacles and many services are not adapted to their needs: the gender perspective in addiction programmes is a question of therapeutic effectiveness and human rights

  3. Addiction Treatment for Adolescents

    19/07/2024 -

    Addiction treatment from a child rights perspective: an outstanding issue in the care of young adolescents

  4. Supporting Transgender Women Engaged in Sex Work

    04/07/2024 -

    It is essential to implement a psychosocial intervention model tailored to the realities of transgender women engaged in the sex trade

  5. A Triad of Exclusion: Mental Health, Maternity and Stigma

    03/06/2024 -

    The stigma of mental health problems in pregnant women or mothers has an impact on their health and the development of their children

  6. WFTC World Social Report

    14/03/2024 -

    WFTC second World Social Report presents a detailed overview of the reality of therapeutic communities globally

  7. Declaration of Oviedo – A Global Initiative for the Prevention of Drug Use

    24/01/2024 -

    Civil society organizations have the opportunity to endorse the Oviedo Declaration and support the initiative by signing it

  8. Mental health, human rights and legislation

    17/01/2024 -

    Mental health, human rights and legislation: guidance and practice, A publication by: WHO team Mental Health and Substance Use

  9. Addiction and Justice: Preserving Adolescents’ Rights

    01/12/2023 -

    In Mexico, a therapeutic community dedicated to treating mental health and addiction problems in adolescents in conflict with the law

  10. People Who Use Drugs and Mental Health

    17/11/2023 -

    A position paper developed by the Civil Society Forum on Drugs (CSFD), an expert group of the European Commission